Temporal association of Streptococcus, Staphylococcus, and parainfluenza pediatric hospitalizations and hospitalized cases of Henoch-Schönlein purpura

Journal of Rheumatology

Volumn 37, Issue 12, 2010, Pages 2587-2594

  Weiss, Pamela F ^a,b   Klink, Andrew J ^a   Luan, Xianqun ^a   Feudtner, Chris ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epidemiology; Henoch Sch nlein purpura; Infection; Pediatric rheumatology; Vasculitis

Indexed keywords

ADENOVIRUS; ADOLESCENT; ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CHILD HOSPITALIZATION; CLUSTER ANALYSIS; COHORT ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PARAINFLUENZA VIRUS INFECTION; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCESS MODEL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; PARAMYXOVIRIDAE INFECTIONS; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TIME FACTORS;

EID: 78649735344     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100364     Document Type: Article

References (49)

1. Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol 1996;23:1968-74.
2. Rostoker G. Schonlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001;15:99-138. (Pubitemid 32336911)
3. Ozen S, Ruperto N, Dillon M, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.
4. Saulsbury FT. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schonlein purpura. J Rheumatol 1997;24:2246-9.
5. Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998;13:930-4.
6. Lofters WS, Pineo GF, Luke KH, Yaworsky RG. Henoch-Schonlein purpura occurring in three members of a family. Can Med Assoc J 1973;109:46-8.
7. Motoyama O, Iitaka K. Familial cases of Henoch-Schonlein purpura in eight families. Pediatr Int 2005;47:612-5.
8. Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schonlein purpura. J Pediatr 2003;143:658-61.
9. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53.
10. Ting TV, Hashkes PJ. Update on childhood vasculitides. Curr Opin Rheumatol 2004;16:560-5.
11. Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001;80:279-90. (Pubitemid 32879289)
12. Abe T, Tokuda Y, Ohde S, Ishimatsu S, Nakamura T, Birrer RB. The relationship of short-term air pollution and weather to ED visits for asthma in Japan. Am J Emerg Med 2009;27:153-9.
13. Fletcher DM. Achieving data quality. How data from a pediatric health information system earns the trust of its users. J AHIMA 2004;75:22-6.
14. Atkinson S, Barker DJ. Proceedings: Henoch-Schonlein purpura in Southampton. Br J Prev Soc Med 1974;28:66-7.
15. Atkinson SR, Barker DJ. Seasonal distribution of Henoch-Schonlein purpura. Br J Prev Soc Med 1976;30:22-5.
16. Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999;78:395-409.
17. Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Child Educ Pract Ed 2008;93:1-8.
18. Al-Sheyyab M, Batieha A, el-Shanti H, Daoud A. Henoch-Schonlein purpura and streptococcal infection: a prospective case-control study. Ann Trop Paediatr 1999;19:253-5.
19. Al-Sheyyab M, el-Shanti H, Ajlouni S, Batieha A, Daoud AS. Henoch-Schonlein purpura: clinical experience and contemplations on a streptococcal association. J Trop Pediatr 1996;42:200-3.
20. Farley TA, Gillespie S, Rasoulpour M, Tolentino N, Hadler JL, Hurwitz E. Epidemiology of a cluster of Henoch-Schonlein purpura. Am J Dis Child 1989;143:798-803.
21. Masuda M, Nakanishi K, Yoshizawa N, Iijima K, Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schonlein nephritis. Am J Kidney Dis 2003;41:366-70.
22. Kaneki T, Kawashima A, Hayashida M, Yamaguchi S, Ogasawara H, Tsushima K, et al. A case of Henoch-Schonlein purpura occurred after methicillin-resistant Staphylococcus aureus enterocolitis. Nippon Shokakibyo Gakkai Zasshi 2000;97:1278-82.
23. Eftychiou C, Samarkos M, Golfinopoulou S, Skoutelis A, Psarra A. Henoch-Schonlein purpura associated with methicillin-resistant Staphylococcus aureus infection. Am J Med 2006;119:85-6.
24. Hirayama K, Kobayashi M, Kondoh M, Muro K, Iwabuchi S, Yoh K, et al. Henoch-Schonlein purpura nephritis associated with methicillin-resistant Staphylococcus aureus infection. Nephrol Dial Transplant 1998;13:2703-4.
25. Temkiatvises K, Nilanont Y, Poungvarin N. Stroke in Henoch-Schonlein purpura associated with methicillin-resistant Staphylococcus aureus septicemia: report of a case and review of the literature. J Med Assoc Thai 2008;91:1296-301.
26. Kitamura T, Nakase H, Iizuka H. Henoch-Schonlein purpura after postoperative Staphylococcus aureus infection with hepatic IgA nephropathy. J Nephrol 2006;19:687-90.
27. Uggeri S, Fabbian F, Catizone L. Henoch-Schonlein purpura due to methicillin-sensitive Staphylococcus aureus bacteremia from central venous catheterization. Clin Exp Nephrol 2008;12:219-23.
28. Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, et al. A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan. Rheumatology 2005;44:618-22.
29. Dolezalova P, Telekesova P, Nemcova D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004;31:2295-9.
30. Ives AR, Abbott KC, Ziebarth NL. Analysis of ecological time series with ARMA(p,q) models. Ecology 2010;91:858-71.
31. Lin CC. Analysis of unpredictable intra-QRS potentials in signal-averaged electrocardiograms using an autoregressive moving average prediction model. Med Eng Phys 2010;32:136-44.
32. Dale RC. Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol 2005;47:785-91.
33. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behcet's disease. Eur J Dermatol 2008;18:489-98.
34. Fink CW. The role of the streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa. J Rheumatol 1991;18 Suppl 29:14-20.
35. Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol 2004;25:61-6.
36. Yuki N, Odaka M. Ganglioside mimicry as a cause of Guillain-Barre syndrome. Curr Opin Neurol 2005;18:557-61.
37. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, et al. Bacterial induction of autoantibodies to beta 2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002;109:797-804.
38. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002;46:545-52. (Pubitemid 34136593)
39. Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J 2000;19:91-4.
40. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7.
41. Popa ER, Stegeman CA, Abdulahad WH, van der Meer B, Arends J, Manson WM, et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology 2007;46:1029-33.
42. Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis. Clin Exp Immunol 2003;132:496-504.
43. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2006;2:661-70.
44. Pendergraft WF 3rd, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, et al. Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004;10:72-9.
45. Duhaut P, Bosshard S, Dumontet C. Giant cell arteritis and polymyalgia rheumatica: role of viral infections. Clin Exp Rheumatol 2000;18 Suppl:S22-3.
46. Johnson D, Azimi P. Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection. Pediatr Infect Dis 1985;4:100.
47. Schnaar DA, Bell DM. Kawasaki syndrome in two cousins with parainfluenza virus infection. Am J Dis Child 1982;136:554-5.
48. Friedman HM, Macarak EJ, MacGregor RR, Wolfe J, Kefalides NA. Virus infection of endothelial cells. J Infect Dis 1981;143:266-73.
49. Keim DE, Keller EW, Hirsch MS. Mucocutaneous lymph-node syndrome and parainfluenza 2 virus infection. Lancet 1977;2:303.